Krystal Biotech, Inc. (NASDAQ: KRYS) awarded Janney Daniel 1,658 derivative securities at $0 per share on 14 September 2026. Daniel is identified as a director of Krystal Biotech, Inc.
LivaNova PLC (NASDAQ: LIVN) awarded Chief Legal Officer Liddy Anne M. 6,291 derivative securities, with the transaction representing about 100.0% of her resulting derivative securities holding. The filing dates the transaction to September 15, 2026.
Moderna, Inc. (NASDAQ: MRNA) President Hoge Stephen exercised options for 152,905 shares at $12.21 per share across two transactions between 14 September 2026 and 15 September 2026. Following these transactions, he owned 1,602,310 shares.
Myriad Genetics Inc. (NASDAQ: MYGN) appointed Vishal Sikri as executive vice president, commercial, effective September 16, 2026.
Phreesia, Inc. (NYSE: PHR) awarded 6,490 shares at $0 per share to Amy Beth VanDuyn, its SVP, Human Resources. The award occurred on September 14, 2026.
Azenta, Inc. (NASDAQ: AZTA) awarded Chief Accounting Officer Erik J. Bello 4,586 shares, creating a reported executive holding of the same size. The shares were awarded at $0 per share.
Clene Inc. (NASDAQ: CLNN) agreed to issue and sell 1,219,513 shares of common stock at $3.28 per share, with gross proceeds expected to reach approximately $4.0 million. The plannedCapitalwould support regulatory dialogue and preparation of filings for lead drug candidate CNM-Au8, while also funding …
Wai Conrad, CEO of Counterpart Health, sold 300,000 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ: CLOV) at $4.72 per share on Sep. 15, 2026. The transaction involved CLOVER Health stock and was classified with transaction code S. The reported price was $4.72 per …
Co-Diagnostics hosted an investor and analyst presentation on September 16, 2026, covering its ReadyGo Diagnostics collaboration, Co-Dx PCR platform, development activities,Manufacturinginitiatives and India operations. The presentation materials give investors the company’s stated agenda for its collaboration, platform development and operating initiatives.Key HighlightsDwight Egan signed …
BRADLEY WILLIAM bought 64,516 shares of Fractyl Health, Inc. (NASDAQ: GUTS) at $0.62 per share on Sep. 14. The purchase represented about 43.3% of Bradley William’s resulting holding in Fractyl Health.